The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 20, 2026
Filed:
Mar. 15, 2024
Takeda Pharmaceutical Company Limited, Osaka, JP;
Mitsunori Kono, Kanagawa, JP;
Yusuke Sasaki, Kanagawa, JP;
Yuya Oguro, Kanagawa, JP;
Zenichi Ikeda, Kanagawa, JP;
Osamu Kubo, Kanagawa, JP;
Masaki Seto, Kanagawa, JP;
Toru Yamashita, Kanagawa, JP;
Makoto Kamata, Kanagawa, JP;
Kenjiro Sato, Kanagawa, JP;
Matthew Thomas Reynolds, Kanagawa, JP;
Kazuaki Takami, Kanagawa, JP;
Asato Kina, Kanagawa, JP;
Takafumi Yukawa, Kanagawa, JP;
Minoru Nakamura, Kanagawa, JP;
Taku Kamei, Kanagawa, JP;
Hiroyuki Kakei, Kanagawa, JP;
Fumie Yamaguchi, Kanagawa, JP;
Tomohiro Ohashi, Kanagawa, JP;
Keiko Kakegawa, Kanagawa, JP;
Takuto Kojima, Kanagawa, JP;
Florian Pünner, Kanagawa, JP;
Masataka Murakami, Kanagawa, JP;
Takahiko Taniguchi, Kanagawa, JP;
Tatsuki Koike, Kanagawa, JP;
Yuichi Kajita, Kanagawa, JP;
Yuhei Miyanohana, Kanagawa, JP;
Kohei Takeuchi, Kanagawa, JP;
Yoshiteru Ito, Kanagawa, JP;
Norihito Tokunaga, Kanagawa, JP;
Yasushi Hattori, Kanagawa, JP;
Eiji Kimura, Kanagawa, JP;
Martin Alexander Pawliczek, Kanagawa, JP;
Marilena Pira, Kanagawa, JP;
Shuhei Ikeda, Kanagawa, JP;
Noriyuki Tezuka, Kanagawa, JP;
Yoshikazu Watanabe, Kanagawa, JP;
Kevin Curran, San Diego, CA (US);
Nicolle Doering, San Diego, CA (US);
Maria Hopkins, San Diego, CA (US);
Ben Johnson, San Diego, CA (US);
Andre Kiryanov, San Diego, CA (US);
Jon Lam, San Diego, CA (US);
Sean Murphy, San Diego, CA (US);
Natasha O'rourke, San Diego, CA (US);
Holly Reichard, San Diego, CA (US);
Paul Tanis, San Diego, CA (US);
Yunlong Zhang, San Diego, CA (US);
Takeda Pharmaceutical Company Limited, Osaka, JP;
Abstract
The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile